Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Health Tech
STAT+

What Sanofi’s withdrawal from diabetes tech tells us about digital health

  • Rebecca Robbins

By Rebecca Robbins Dec. 11, 2019

Reprints
Blood sugar monitor - finger stick
Joerg Sarbach/AP

A version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe.

In health care, major drug makers have sought to collaborate with health tech up-and-comers. And on the surface, there’s good reason to think that these partnerships can translate into products that can benefit human health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

9 ways Covid-19 may forever upend the U.S. health…
9 ways Covid-19 may forever upend the U.S. health care industry
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4…
‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
Pharmalittle: Sanofi cuts price on a popular insulin by…
Pharmalittle: Sanofi cuts price on a popular insulin by 78%; Califf criticizes insurers for doing too…
To prevent emergency C-sections, researchers turn to AI to…
To prevent emergency C-sections, researchers turn to AI to predict the course of childbirth
Momentum grows to subject medical devices to medicine’s gold…
Momentum grows to subject medical devices to medicine’s gold standard — the placebo treatment

Recommended Stories